The antitumor effect and systemic toxicity of the OXA/anti-PD-L1 co-loaded hydrogel were evaluated in vivo via intratumoral administration in C57BL/6 mice bearing B16F10 melanoma tumors. Here, CD274 is linked to melanoma.